SonoScape Medical Corp. (SHE:300633)
China flag China · Delayed Price · Currency is CNY
25.91
+0.66 (2.61%)
At close: Mar 6, 2026

SonoScape Medical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Jan '24 Jan '23 Jan '22 Dec '20
11,13712,65620,37023,46012,83310,443
Market Cap Growth
-10.73%-37.87%-13.17%82.80%22.89%7.69%
Enterprise Value
10,02111,21218,76122,08812,39910,186
Last Close Price
25.9129.3046.7654.0331.3625.40
PE Ratio
167.2088.8844.8263.4451.91-
Forward PE
41.8025.8734.5857.5350.5878.06
PS Ratio
5.376.299.6113.318.888.98
PB Ratio
3.574.076.488.565.457.76
P/TBV Ratio
3.894.467.249.736.3210.64
P/FCF Ratio
-126.8265.1982.9285.1390.15
P/OCF Ratio
-41.2741.6249.5742.3638.52
EV/Sales Ratio
4.835.578.8512.538.588.76
EV/EBITDA Ratio
128.3068.4236.9561.9450.0459.48
EV/EBIT Ratio
-111.0540.9968.8157.3571.54
EV/FCF Ratio
-43.71112.3560.0478.0782.2687.93
Debt / Equity Ratio
0.100.110.020.080.050.33
Debt / EBITDA Ratio
3.921.940.140.580.412.61
Debt / FCF Ratio
-3.560.230.770.743.86
Net Debt / Equity Ratio
-0.36-0.53-0.56-0.56-0.55-0.34
Net Debt / EBITDA Ratio
-18.89-10.10-3.45-4.31-5.26-2.64
Net Debt / FCF Ratio
4.87-16.58-5.61-5.43-8.65-3.91
Asset Turnover
0.500.500.580.540.550.50
Inventory Turnover
1.031.331.381.311.421.37
Quick Ratio
1.912.083.552.643.001.40
Current Ratio
3.042.754.623.363.841.80
Return on Equity (ROE)
2.15%4.55%15.44%14.52%13.36%-3.36%
Return on Assets (ROA)
-0.20%1.56%7.82%6.11%5.13%3.81%
Return on Invested Capital (ROIC)
-0.69%7.09%33.84%27.59%21.64%14.99%
Return on Capital Employed (ROCE)
-0.40%3.10%14.30%11.50%8.80%10.00%
Earnings Yield
0.60%1.13%2.23%1.58%1.93%-0.44%
FCF Yield
-2.06%0.79%1.53%1.21%1.18%1.11%
Dividend Yield
0.39%0.34%0.68%0.33%0.40%-
Payout Ratio
72.38%101.36%18.20%15.62%2.24%-
Buyback Yield / Dilution
0.68%0.30%-0.65%-7.83%-3.44%5.08%
Total Shareholder Return
1.07%0.64%0.04%-7.50%-3.04%5.08%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.